These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26903266)

  • 1. Evaluation of neopterin as a biomarker for the monitoring of Gaucher disease patients.
    Drugan C; Drugan TC; Miron N; Grigorescu-Sido P; Naşcu I; Cătană C
    Hematology; 2016 Jul; 21(6):379-86. PubMed ID: 26903266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling long-term evolution of chitotriosidase in non-neuronopathic Gaucher disease.
    Drugan C; Drugan TC; Grigorescu-Sido P; Naşcu I
    Scand J Clin Lab Invest; 2017 Jul; 77(4):275-282. PubMed ID: 28319420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma chitotriosidase activity versus CCL18 level for assessing type I Gaucher disease severity: protocol for a systematic review with meta-analysis of individual participant data.
    Raskovalova T; Deegan PB; Yang R; Pavlova E; Stirnemann J; Labarère J; Zimran A; Mistry PK; Berger M
    Syst Rev; 2017 Apr; 6(1):87. PubMed ID: 28427477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison and clinical application of two methods for determination of plasma chitotriosidase activity].
    Wang Y; Zhang HW; Ye J; Qiu WJ; Han LS; Gu XF
    Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):834-8. PubMed ID: 23302614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaucher disease: a model disorder for biomarker discovery.
    Boot RG; van Breemen MJ; Wegdam W; Sprenger RR; de Jong S; Speijer D; Hollak CE; van Dussen L; Hoefsloot HC; Smilde AK; de Koster CG; Vissers JP; Aerts JM
    Expert Rev Proteomics; 2009 Aug; 6(4):411-9. PubMed ID: 19681676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucosylsphingosine is a key biomarker of Gaucher disease.
    Murugesan V; Chuang WL; Liu J; Lischuk A; Kacena K; Lin H; Pastores GM; Yang R; Keutzer J; Zhang K; Mistry PK
    Am J Hematol; 2016 Nov; 91(11):1082-1089. PubMed ID: 27441734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitotriosidase variants in patients with Gaucher disease. Implications for diagnosis and therapeutic monitoring.
    Irún P; Alfonso P; Aznarez S; Giraldo P; Pocovi M
    Clin Biochem; 2013 Dec; 46(18):1804-7. PubMed ID: 24060732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases.
    Aerts JM; Hollak CE; van Breemen M; Maas M; Groener JE; Boot RG
    Acta Paediatr Suppl; 2005 Mar; 94(447):43-6; discussion 37-8. PubMed ID: 15895711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma chitotriosidase activity in Argentinian patients with Gaucher disease, various lysosomal diseases and other inherited metabolic disorders].
    Dodelson de Kremer R; Paschini de Capra A; Angaroni CJ; Giner de Ayala A
    Medicina (B Aires); 1997; 57(6):677-84. PubMed ID: 9674188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin: a potential biomarker of Gaucher disease.
    Vairo F; Sperb-Ludwig F; Wilke M; Michellin-Tirelli K; Netto C; Neto EC; Schwartz I
    Ann Hematol; 2015 Jul; 94(7):1119-25. PubMed ID: 25875742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients.
    Rolfs A; Giese AK; Grittner U; Mascher D; Elstein D; Zimran A; Böttcher T; Lukas J; Hübner R; Gölnitz U; Röhle A; Dudesek A; Meyer W; Wittstock M; Mascher H
    PLoS One; 2013; 8(11):e79732. PubMed ID: 24278166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of high density lipoprotein as a circulating biomarker of Gaucher disease activity.
    Stein P; Yang R; Liu J; Pastores GM; Mistry PK
    J Inherit Metab Dis; 2011 Apr; 34(2):429-37. PubMed ID: 21290183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma chitotriosidase activity versus plasma glucosylsphingosine in wide spectrum of Gaucher disease phenotypes - A statistical insight.
    Tylki-Szymańska A; Szymańska-Rożek P; Hasiński P; Ługowska A
    Mol Genet Metab; 2018 Apr; 123(4):495-500. PubMed ID: 29530534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 20-Year Longitudinal Study of Plasma Chitotriosidase Activity in Treated Gaucher Disease Type 1 and 3 Patients-A Qualitative and Quantitative Approach.
    Szymańska-Rożek P; Czartoryska B; Kleinotiene G; Lipiński P; Tylki-Szymańska A; Ługowska A
    Biomolecules; 2023 Feb; 13(3):. PubMed ID: 36979371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant progranulin, YKL-40, cathepsin D and cathepsin S in Gaucher disease.
    Afinogenova Y; Ruan J; Yang R; Kleytman N; Pastores G; Lischuk A; Mistry PK
    Mol Genet Metab; 2019; 128(1-2):62-67. PubMed ID: 31358474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention.
    Boot RG; Verhoek M; de Fost M; Hollak CE; Maas M; Bleijlevens B; van Breemen MJ; van Meurs M; Boven LA; Laman JD; Moran MT; Cox TM; Aerts JM
    Blood; 2004 Jan; 103(1):33-9. PubMed ID: 12969956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitotriosidase, a marker of innate immunity, is elevated in patients with primary breast cancer.
    Thein MS; Kohli A; Ram R; Ingaramo MC; Jain A; Fedarko NS
    Cancer Biomark; 2017 Jul; 19(4):383-391. PubMed ID: 28582842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of imiglucerase on the serum glycosylated-ferritin level in Gaucher disease.
    Stirnemann J; Boutten A; Vincent C; Mekinian A; Heraoui D; Fantin B; Fain O; Mentré F; Belmatoug N
    Blood Cells Mol Dis; 2011 Jan; 46(1):34-8. PubMed ID: 21084203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease.
    Deegan PB; Moran MT; McFarlane I; Schofield JP; Boot RG; Aerts JM; Cox TM
    Blood Cells Mol Dis; 2005; 35(2):259-67. PubMed ID: 16125420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between serum markers of monocyte/macrophage activation in type 1 Gaucher's disease.
    Casal JA; Lacerda L; Pérez LF; Pinto RA; Clara Sá Miranda M; Carlos Tutor J
    Clin Chem Lab Med; 2002 Jan; 40(1):52-5. PubMed ID: 11924537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.